Stefan Schubert

Max Reinshagen1
Jan Tack1
Henning Wittenburg1
Learn More
  • Stephan Miehlke, Petr Hruz, Michael Vieth, Christian Bussmann, Ulrike von Arnim, Monther Bajbouj +15 others
  • 2016
OBJECTIVE To investigate the efficacy and safety of two different budesonide formulations (effervescent tablet for orodispersible use (BET) and viscous suspension (BVS)) with different daily dosages for short-term treatment of eosinophilic oesophagitis (EoE). DESIGN Adults with active EoE (n=76) randomly received 14 days' treatment with either BET 2×1(More)
  • 1